Latham & Watkins represented SoftBank Vision Fund 2 in the transaction. Ventus Therapeutics, a biopharmaceutical company utilizing structural biology and computational tools to identify and develop small molecule...
Ventus Therapeutics’ $140 Series C Financing
Chevron’s Renewable Fuels Joint Venture with Bunge
Latham & Watkins represented Chevron in the transaction. Chevron U.S.A. Inc., a subsidiary of Chevron Corporation (NYSE: CVX), and Bunge North America, Inc., a subsidiary of Bunge...
Rumichaca – Pasto Motorway Project’s $906 Million Financing
Clifford Chance, Posse Herrera Ruiz and Noboa, Peña & Torres advised Concesionaria Vial Unión del Sur S.A.S., Sacyr Concesiones S.L. and Sudamericana Integral de Construcciones Sudinco...
Churchill Downs’ $2.485 Billion Acquisition of P2E’s Gaming Business
Latham & Watkins represented Peninsula Pacific Entertainment in the transaction while Sidley advised Churchill Downs Incorporated. Churchill Downs Incorporated (Churchill), home of the Kentucky Derby and...
Latham & Watkins elects 17 new Partners
Latham & Watkins LLP is pleased to announce that 17 counsel have been elected to the partnership, effective March 1. The group consists of experienced lawyers...
Apollo Funds’ Acquisition of Worldline’s TSS Unit
Gide advised TSS, while Latham & Watkins and PwC Société d’Avocats advised Worldline on the deal. Worldline, the European leader in payments services, announced the proposed...
Apollo Funds’ $7.1 Billion Acquisition of Tenneco
Latham & Watkins advised Tenneco, while Wachtell, Lipton, Rosen & Katz served as legal counsel and Paul, Weiss, Rifkind, Wharton & Garrison, as financing counsel to...
Eco Material Technologies’ $525 Million Green Bond Offering
Latham & Watkins represented Green Cement on the green bond offering. Eco Material Technologies, a leading producer of sustainable cementitious materials, has completed the acquisitions of...
ICON’s $185 Million Financing Round
Latham & Watkins represented ICON in the transaction. ICON, the leading 3D printing technology homebuilder, has announced that it has raised an addition US$185 million in...
Amgen’s $4 Billion Senior Unsecured Notes Offerings
Latham & Watkins represented Amgen in the offerings. Amgen Inc., one of the world’s leading biotechnology companies, priced on February 17, 2022, a senior unsecured notes...
TPG Capital’s Majority Investment in Confluent Medical Technologies
Latham & Watkins represented TPG Capital in the transaction. Confluent Medical Technologies (Confluent), a leading materials science, development, and manufacturing partner to medical device manufacturers, has...
KKR’s Acquisition of Majority Stake in Refresco
Skadden, Arps, Slate, Meagher & Flom advised Refresco Group, Simpson Thacher & Bartlett represented KKR, while Latham & Watkins and Loyens & Loeff advised Refresco’s shareholders...